Why Antibiotics Alone Fail Against Biofilms
How bacterial biofilms reduce antibiotic efficacy by 100-1,000x, why standard treatment courses miss persistent infections, and what integrative approaches add.
Infectiology
Emerging EvidenceBiofilms
How bacterial biofilms protect persistent infections and strategies to disrupt them.
01
02
Biofilm Disruption Protocols for Chronic Infections
A clinical overview of biofilm disruption strategies for persistent Lyme disease — the three-phase approach of disrupt, kill, and clear.
03
Nattokinase and Serrapeptase for Biofilm Disruption
How proteolytic enzymes nattokinase and serrapeptase degrade biofilm matrix components — mechanism, dosing, evidence, and clinical considerations.
04
LL-37 for Biofilm Disruption in Chronic Lyme
How LL-37 disrupts Borrelia biofilms in chronic Lyme disease. Mechanism, preclinical evidence, protocol context, and clinical observations.
05
Biofilms: Why Infections Persist
How biofilms protect chronic infections from antibiotics and the immune system. Disruption strategies and clinical implications.
